Northern Trust Corp Cerevel Therapeutics Holdings, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

A detailed history of Northern Trust Corp transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 645,282 shares of CERE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
645,282
Previous 675,554 4.48%
Holding current value
$0
Previous $28.6 Million 7.6%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$38.96 - $42.75 $1.18 Million - $1.29 Million
-30,272 Reduced 4.48%
645,282 $26.4 Million
Q1 2024

May 14, 2024
BUY
$40.88 - $43.27 $28,943 - $30,635
708 Added 0.1%
675,554 $28.6 Million
Q4 2023

Feb 13, 2024
BUY
$20.27 - $42.44 $1.62 Million - $3.39 Million
79,868 Added 13.42%
674,846 $28.6 Million
Q3 2023

Nov 13, 2023
BUY
$20.26 - $31.91 $237,042 - $373,347
11,700 Added 2.01%
594,978 $13 Million
Q2 2023

Aug 11, 2023
BUY
$23.9 - $35.38 $710,714 - $1.05 Million
29,737 Added 5.37%
583,278 $18.5 Million
Q1 2023

May 15, 2023
BUY
$22.82 - $35.32 $364,777 - $564,590
15,985 Added 2.97%
553,541 $13.5 Million
Q4 2022

Feb 13, 2023
BUY
$25.35 - $31.96 $716,898 - $903,828
28,280 Added 5.55%
537,556 $17 Million
Q3 2022

Nov 14, 2022
BUY
$25.5 - $41.42 $188,674 - $306,466
7,399 Added 1.47%
509,276 $14.4 Million
Q2 2022

Aug 12, 2022
BUY
$20.62 - $37.15 $1.88 Million - $3.39 Million
91,259 Added 22.22%
501,877 $13.3 Million
Q1 2022

May 13, 2022
SELL
$23.5 - $35.38 $381,170 - $573,863
-16,220 Reduced 3.8%
410,618 $14.4 Million
Q4 2021

Feb 08, 2022
BUY
$29.21 - $44.64 $364,219 - $556,616
12,469 Added 3.01%
426,838 $13.8 Million
Q3 2021

Nov 15, 2021
BUY
$21.26 - $38.85 $735,340 - $1.34 Million
34,588 Added 9.11%
414,369 $12.2 Million
Q2 2021

Aug 13, 2021
BUY
$12.56 - $29.69 $3.9 Million - $9.21 Million
310,180 Added 445.65%
379,781 $9.73 Million
Q1 2021

May 12, 2021
BUY
$12.37 - $17.74 $46,956 - $67,341
3,796 Added 5.77%
69,601 $956,000
Q4 2020

Feb 11, 2021
BUY
$9.82 - $18.27 $646,205 - $1.2 Million
65,805 New
65,805 $1.09 Million

Others Institutions Holding CERE

# of Institutions
270
Shares Held
155M
Call Options Held
2.19M
Put Options Held
3.92M
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email